Iproteos is a biotechnology company determined to improve human health by creating therapeutics for unmet medical needs in the Central Nervous System space.
The company focuses its activity on the development of new therapeutic strategies based on the modulation of protein-ligand (PLI) and protein-protein interactions (PPIs) through novel small molecules obtained through the proprietary platform IPROTech.